Aimee Crombie
Senior Vice President and Head of Strategic Planning and Operations at Prelude Therapeutics - Wilmington, Delaware, US
Aimee Crombie's Colleagues at Prelude Therapeutics
Christopher Pierce
Executive Vice President, Chief of Business Operations
Aimee Crombie's Contact Details
(302) 467-1280
Prelude Therapeutics
Aimee Crombie's Company Details
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways forcancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: PRT3789 an IV administered, potent and highly selective SMARCA2 degrader, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645 a next generation CDK4/6 inhibitor, and a preclinical oral candidate targeting SMARCA2.